Indonesia, Philippines, Vietnam and Brazil
Happy Friday! Here’s your weekly must-read update from Rosapharma. Contact us with any questions or feedback. Indonesia: Health Supplements 2025 Agenda BPOM (the Indonesian Food and Drug Agency) has published its Regulatory Roadmap for 2025, identifying Health Supplements as a key focus area. Some of the key areas addressed are: […]
Brazil: ANVISA Novel Foods Tool | New Upper Limit for Creatine
Happy Friday! Here’s your weekly must-read update from Rosapharma. Contact us with any questions or feedback. Withdrawal and Recall from the Market Products Containing Garcinia cambogia As of April 18, the sale, importation, and introduction of Food Supplements containing Garcinia cambogia will be suspended in France for 1 year. This decision […]
Brazil: Public Consultation on Ingredient Specs | Ban on Food Supplements with ora-pro-nobis | Safe Use of Erythrosine | Update on Plastic Packaging
Happy Friday! Here’s your weekly must-read update from Rosapharma. Contact us with any questions or feedback. Withdrawal and Recall from the Market Products Containing Garcinia cambogia As of April 18, the sale, importation, and introduction of Food Supplements containing Garcinia cambogia will be suspended in France for 1 year. […]
Brazil: New normative of specifications for ingredients (new ingredients and novel foods)
Last week, Brazil approved a new Normative Instruction that will regulate petitions in the food sector based on approvals already granted by Equivalent Authorities from Foreign Countries (known as Autoridades Reguladores Estrangeiras Equivalentes – AREEs – in Portuguese). This new norm is a significant step toward streamlining Brazil’s approval system, as it will allow petitions submitted to ANVISA to reference […]
